Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 28, 2016 | Promethera Biosciences | $10.9M Series C Extension | — | Boehringer Ingelheim, Cell Innovation Partners, Fund+, LifeLiver, Muneki Handa, SRIW, Vesalius Biocapital |
| Nov 25, 2014 | Promethera Biosciences | $25.4M Series C | Boehringer Ingelheim, Vesalius Biocapital | Mitsui & Co. Global Investment, Pall-ATMI LifeSciences, SFPI-FPIM, Shire, SRIW, VIVES Louvain Technology Fund |